$SRPT Sarepta Therapeutics, Inc. Insider Trading Week 29/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Sarepta Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Sarepta Therapeutics, Inc. in week 29/2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 23.85 | 1,500 | 35,775 | 14,268 | |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 23.85 | 7,627 | 181,904 | 125,605 | |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 13.90 | 32,998 | 458,672 | 56,866 | |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 13.71 | 9,375 | 128,531 | 24,591 | |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 23.85 | 1,500 | 35,775 | 33,861 | 32.4 K to 33.9 K (+4.64 %) |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Sell | S | 41.00 | 7,627 | 312,707 | 32,361 | 40 K to 32.4 K (-19.07 %) |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 23.85 | 7,627 | 181,904 | 39,988 | 32.4 K to 40 K (+23.57 %) |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Sell | S | 41.00 | 32,998 | 1,352,918 | 32,361 | 65.4 K to 32.4 K (-50.49 %) |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 13.90 | 32,998 | 458,672 | 65,359 | 32.4 K to 65.4 K (+101.97 %) |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Sell | S | 41.00 | 9,375 | 384,375 | 32,361 | 41.7 K to 32.4 K (-22.46 %) |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 13.71 | 9,375 | 128,531 | 41,736 | 32.4 K to 41.7 K (+28.97 %) |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | Director | Sell | S | 41.00 | 10,000 | 410,000 | 52,471 | 62.5 K to 52.5 K (-16.01 %) |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Kaye Edward M. MD | Director | Payment of Exercise | F | 40.93 | 4,349 | 178,005 | 62,471 | 66.8 K to 62.5 K (-6.51 %) |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Option Exercise | M | 14.76 | 1,500 | 22,140 | 52,644 | |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Option Exercise | M | 13.90 | 4,388 | 60,993 | 5,098 | |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Option Exercise | M | 13.71 | 6,250 | 85,688 | 17,708 | |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Buy | S | 44.00 | 1,500 | 66,000 | 21,062 | 19.6 K to 21.1 K (+7.67 %) |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Buy | M | 14.76 | 1,500 | 22,140 | 22,562 | 21.1 K to 22.6 K (+7.12 %) |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Sell | S | 44.00 | 4,388 | 193,072 | 21,062 | 25.5 K to 21.1 K (-17.24 %) |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Buy | M | 13.90 | 4,388 | 60,993 | 25,450 | 21.1 K to 25.5 K (+20.83 %) |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Sell | S | 42.00 | 6,250 | 262,500 | 21,062 | 27.3 K to 21.1 K (-22.88 %) |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Buy | M | 13.71 | 6,250 | 85,688 | 27,312 | 21.1 K to 27.3 K (+29.67 %) |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | M | 23.85 | 676 | 16,123 | 15,092 | |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | M | 13.71 | 324 | 4,442 | 93 | |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | M | 13.71 | 5,944 | 81,492 | 19,146 | |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | M | 13.71 | 19,056 | 261,258 | 10,527 | |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Buy | M | 23.85 | 676 | 16,123 | 23,301 | 22.6 K to 23.3 K (+2.99 %) |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Buy | M | 13.71 | 324 | 4,442 | 22,625 | 22.3 K to 22.6 K (+1.45 %) |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Sell | S | 41.00 | 5,944 | 243,704 | 22,301 | 28.2 K to 22.3 K (-21.04 %) |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Buy | M | 13.71 | 5,944 | 81,492 | 28,245 | 22.3 K to 28.2 K (+26.65 %) |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Sell | S | 41.00 | 19,056 | 781,296 | 22,301 | 41.4 K to 22.3 K (-46.08 %) |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Buy | M | 13.71 | 19,056 | 261,258 | 41,357 | 22.3 K to 41.4 K (+85.45 %) |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Option Exercise | M | 13.71 | 2,500 | 34,275 | 15,774 | |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Sell | S | 41.00 | 3,418 | 140,138 | 16,875 | 20.3 K to 16.9 K (-16.84 %) |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Sell | S | 41.00 | 2,500 | 102,500 | 20,293 | 22.8 K to 20.3 K (-10.97 %) |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Buy | M | 13.71 | 2,500 | 34,275 | 22,793 | 20.3 K to 22.8 K (+12.32 %) |